Nautilus Biotechnology, Inc. - Common Stock — movimiento de fondos (NASDAQ:NAUT) | MetaTrader

Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas

Flujo de caja de las actividades operativas —-39.24 M-45.81 M-51.71 M-59.15 M-50.7 M -49.86 M Flujo de caja de las actividades de inversión —-138.96 M-25.74 M-43.73 M66.25 M35.22 M 29.95 M Flujo de caja de las actividades financieras —327.45 M562 K368 K1.14 M214 K 1.3 M Flujo de caja libre —-39.24 M-45.81 M-51.71 M-59.15 M-51.97 M -51.43 M

Noticias

3 Small-Cap Stocks to Buy Before May 15

Brain Computer Interface Stocks: 10 Plays Beyond Neuralink

Nautilus Biotechnology en cumbre de inversores: camino innovador en proteómica

Nautilus Biotechnology, Inc. (NAUT) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Nautilus Biotechnology appoints Amber Faust as VP of sales

AMD, IONQ: Amazon Exits Stakes in Advanced Micro Devices and IonQ - TipRanks.com

Nautilus Biotechnology en Cumbre de Inversores Q3: Impulso a la proteómica

Nautilus Biotechnology en la Cumbre de Inversores del T3: Impulso a la Proteómica

Nautilus Biotechnology at Q3 Investor Summit: Proteomics Push

Nautilus at Goldman Sachs Conference: Proteomics Market Potential

Nautilus: Trading Below An Albeit Lower Net Cash Figure (NASDAQ:NAUT)

Nautilus Biotechnology, Inc. (NAUT) Q4 2024 Earnings Call Transcript